Esperion to Participate in Upcoming Virtual Investor Conference

ANN ARBOR, Mich., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that members of Esperion’s management team will participate in the upcoming Credit Suisse 30^th Annual Healthcare Conference.

Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.

Esperion Therapeutics

Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Investor Contact:
Kaitlyn Brosco
Esperion
[email protected] 

You May Also Be Interested In

• SIKA DELIVERS STRONG NINE-MONTH RESULTS WITH 4.8% SALES GROWTH IN LOCAL CURRENCIES AND REITERATES 2026 GUIDANCE
• LianLian Global and PayPal Power Cross-Border Payouts for Social Commerce, Marketplace, and eCommerce Customers
• Endometriosis Pain Pipeline Insights 2026: Novel Mechanisms, Promising Candidates, and Competitive Landscape by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie